• Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson's disease

    One year ago - By News Medical

    Parkinson's disease is currently the second most widespread neurogenerative pathology. Current therapies are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed.
    Read more ...